Article
Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?
9 Jul 2018
Abstract excerpt
The latest response to consumers’ increased demand for accessible genetic health information is the US Food and Drug Administration (FDA)’s recent approval of 23andMe’s direct-to-consumer (DTC) genetic test for the three common BRCA1 and BRCA2 pathogenic variants found in the Ashkenazi Jewish population.1 23andMe and other DTC genetic testing companies officially report out ancestry, trait, and some health...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
